Overview
The SS-31 + MOTS-c Bundle combines two mitochondrial-focused research peptides with distinct but complementary mechanisms. In laboratory research settings, this pairing enables investigation into how mitochondrial membrane–associated signaling interfaces with mitochondrial-derived peptide regulation within controlled experimental models.
This bundle is supplied strictly for laboratory and investigational research purposes.
Compound Breakdown
Each peptide contributes a unique mitochondrial signaling role:
SS-31 – Elamipretide (50mg)— studied for its selective localization to the inner mitochondrial membrane and interaction with cardiolipin-associated signaling pathways
MOTS-c (40mg)— investigated as a mitochondrial-derived peptide involved in intracellular metabolic regulation and mitochondrial–nuclear signaling communication
Together, these compounds allow researchers to examine mitochondrial signaling across both membrane-level and peptide-mediated regulatory layers.
Research Context
Research investigations involving the SS-31 + MOTS-c Bundle commonly explore:
Mitochondrial bioenergetic signaling frameworks
Membrane-associated mitochondrial regulation models
Comparative studies versus single-mechanism mitochondrial research compounds
Integrated mitochondrial signaling architecture investigations
These investigations remain limited to controlled laboratory environments and do not imply clinical or therapeutic outcomes.
Related Categories
Researchers evaluating this bundle often review the individual components — SS-31 (Elamipretide) Peptide and MOTS-c Peptide — as well as metabolic-focused formulations such as Metabolic Bundle I: Classic and Metabolic Bundle II: Synergy.
